Investegate |LIDDS AB Announcements | LIDDS AB: LIDDS announces successful stage 1 in R&D project
Investegate announcements from LIDDS AB, LIDDS announces successful stage 1 in R&D project
Stay updated with breaking news from Lidds Ab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from LIDDS AB, LIDDS announces successful stage 1 in R&D project
Investegate announcements from LIDDS AB, LIDDS announces positive topline results from the phase I dose-escalating study of NanoZolid®-formulated docetaxel
Investegate announcements from LIDDS AB, LIDDS patent covering the NanoZolid® production process granted in China
Investegate announcements from LIDDS AB, NanoZolid®-formulated Docetaxel is Safe and Tolerable Showing Signs of Clinical Efficacy
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that a patent application related to NanoZolid® for treatment of brain cancers was filed to the European...